Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2021 PDA/FDA Joint Regulatory Conference
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
P
Pfeiler, Erika
U.S. FDA
Live Q&A (A2)
Erika Pfeiler
Favorite
The Complex: Science, Policy, and Case Studies of the Burkholderia Cepacia Complex in Aqueous Nonsterile Drugs
Erika Pfeiler
Favorite
Piepoli, Michele
Johnson & Johnson
Creating and Sustaining a Quality Mindset
Michele Piepoli
Favorite
Live Q&A (A3)
Michele Piepoli
Favorite
Pitts, Simone
U.S. FDA
Live Q&A (B5)
Simone Pitts
Favorite
Sterile Drug Hot Topics
Simone Pitts
Favorite
Plumb, Laura
Bionique Testing Laboratories
2: An Evaluation of Comparability Between an Alternative NAT Method Using Multiplex PCR and the Compendial USP <63> Culture-Based Method
Laura Plumb
Favorite
2: An Evaluation of Comparability Between an Alternative NAT Method Using Multiplex PCR and the Compendial USP <63> Culture-Based Method
Laura Plumb
Favorite
Polarine, James
STERIS Corporation
1: A Disinfectant Field Trial that Meets Annex I Guidance
James Polarine
Favorite
1: A Disinfectant Field Trial that Meets Annex I Guidance
James Polarine
Favorite
Porte, Quallyna
U.S. FDA
Inspection-Based Live Q&A
Quallyna Porte
Favorite
Inspection-Based Panel Discussion
Quallyna Porte
Favorite
Back to Top